We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

72 hedge funds and large institutions have $1.01B invested in Kronos Bio in 2020 Q4 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60.89% more ownership

Funds ownership: 0% → 60.89% (+61%)

Holders
72
Holders Change
+72
Holders Change %
–
% of All Funds
1.27%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
72
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
+$120M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$111M
3
PA
Perceptive Advisors
New York
+$87.2M
4
VVA
Vida Ventures Advisors
Massachusetts
+$86.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$80.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OFM
1
Omega Fund Management
Massachusetts
$114M +$120M +3,818,283 New
Capital Research Global Investors
2
Capital Research Global Investors
California
$103M +$111M +3,541,573 New
PA
3
Perceptive Advisors
New York
$83M +$87.2M +2,780,097 New
VVA
4
Vida Ventures Advisors
Massachusetts
$82.6M +$86.8M +2,765,314 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$73M +$80.6M +2,567,902 New
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$61.7M +$66.3M +2,113,578 New
JP Morgan Chase
7
JP Morgan Chase
New York
$47.9M +$50.3M +1,604,761 New
BlackRock
8
BlackRock
New York
$45.6M +$47.9M +1,526,688 New
AI
9
Alphabet Inc
California
$43M +$45.1M +1,438,232 New
WCM
10
Wildcat Capital Management
New York
$43M +$45.1M +1,438,232 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$42.4M +$44.5M +1,419,287 New
AG
12
Artal Group
Luxembourg
$39.4M +$41.3M +1,317,954 New
Citadel Advisors
13
Citadel Advisors
Florida
$27.9M +$29.3M +932,885 New
Victory Capital Management
14
Victory Capital Management
Texas
$19.9M +$20.9M +666,437 New
HA
15
HHLR Advisors
Cayman Islands
$19.7M +$20.7M +658,436 New
Capital International Investors
16
Capital International Investors
California
$17.9M +$18.8M +600,000 New
CC
17
Casdin Capital
New York
$17.4M +$18.3M +583,436 New
PCIG
18
Partners Capital Investment Group
Massachusetts
$15.8M +$16.5M +527,500 New
EC
19
EcoR1 Capital
California
$11.6M +$12.2M +387,357 New
Invesco
20
Invesco
Georgia
$11.3M +$11.9M +377,756 New
CC
21
Commodore Capital
New York
$8.93M +$9.38M +298,839 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$7.52M +$7.89M +251,642 New
State Street
23
State Street
Massachusetts
$6.71M +$7.05M +224,605 New
WP
24
Woodline Partners
California
$6.62M +$6.95M +221,487 New
Ensign Peak Advisors
25
Ensign Peak Advisors
Utah
$6.39M +$6.71M +213,891 New
1
2 3

KRON Hedge Fund Activity: Q4 2020 in Review

72 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q4 2020, worth a combined $1.01B.

Buyers outnumbered sellers: 72 funds opened new KRON positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Omega Fund Management, opening a new position worth an estimated $120M.

  • 72 institutional investors held Kronos Bio (KRON) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $1.01B of Kronos Bio stock for Q4 2020.
  • 72 funds opened new Kronos Bio positions in Q4 2020 and 0 closed out, a net change of +72 holders.
  • The largest Kronos Bio buyer in Q4 2020 was Omega Fund Management, an estimated $120M added.

Based on aggregated 13F filings for Q4 2020.